These national and regional barriers, which range from cost of screening to patient education, have hindered the widespread use of screening, say the researchers. Genetic testing is becoming ...

Reactions to low rates of molecular testing for patients with non-small cell lung cancer in community settings. Charu Aggarwal, M.D., MPH: Recent data show that there are many challenges. We saw ...

MINNEAPOLIS (WCCO) -- A saliva testing site will be opening in Worthington Thursday, bringing the state's total number of community testing sites to 22 across the state. Minnesota Health Commissioner ...

Please provide your email address to receive an email when new articles are posted on . Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers ...

Biomarker testing has become increasingly important for making informed, personalized treatment decisions for patients with cancer. However, a new nationwide survey conducted by the American Cancer ...

Jorge Nieva, MD, highlights the critical role of molecular testing in non–small cell lung cancer (NSCLC) care, while addressing barriers such as limited tissue samples, delayed turnaround times, and ...